Title : Low-dose Methotrexate for Vitiligo.

Pub. Date : 2017 Jul 1

PMID : 28697225






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Though vitiligo is an autoimmune disease, there is no current data to support systemic immunosuppressive monotherapy.</p> <p>CASE SUMMARY: Here we present a case series of 3 patients with vitiligo treated for 11-16 months with low-dose methotrexate (12.5-25 mg per week) with folic acid supplementation with clinically significant skin repigmentation, with response within 6 months in one case. Folic Acid VAMAS6 Homo sapiens